Cleared Traditional

K831413 - SPEC IISX

K831413 is an FDA 510(k) clearance for SPEC IISX, manufactured by Medical Devices, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 37-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1983
Decision
37d
Days
Class 2
Risk

K831413 is an FDA 510(k) clearance for the SPEC IISX. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medical Devices, Inc. (Mchenry, US). The FDA issued a Cleared decision on June 8, 1983 after a review of 37 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K831413

510(k) Number K831413 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 1983
Decision Date June 08, 1983
Days to Decision 37 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
112d faster than avg
Panel avg: 149d · This submission: 37d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K831413.
OMNIPROBE ELECTRICAL NERVE STIMULATOR
K831147 · Omni Intl., Inc. · Jul 1983
ALPHA-STIM 350
K831145 · Electromedical Products, Inc. · Jul 1983
ALPHA-STIM 2000
K831144 · Electromedical Products, Inc. · Jun 1983
PC 2909A-HEALTH PULSE CONTROL STIMULATOR
K830747 · J.A. Preston Corp. · May 1983
NYNEX II
K830932 · La Jolla Technology, Inc. · Apr 1983
PULSETTE 110 TRANSCUTANEOUS ELEC-NERVE
K830792 · Bomed Medical Mfr., Ltd. · Mar 1983